1. Integrating phosphoproteomics into kinase-targeted cancer therapies in precision medicine
   Xiaomo Wu et al, 2019, Journal of Proteomics CrossRef
2. PIM1 kinase promotes gallbladder cancer cell proliferation via inhibition of proline-rich Akt substrate of 40 kDa (PRAS40)
   Tejaswini Subbannayya et al, 2019, Journal of Cell Communication and Signaling CrossRef
3. Proline-rich AKT substrate of 40-kDa (PRAS40) in the pathophysiology of cancer
   Ritu Malla et al, 2015, Biochemical and Biophysical Research Communications CrossRef
4. Mutation distributions and clinical correlations of PIK3CA gene mutations in breast cancer
   Ebubekir Dirican et al, 2016, Tumor Biology CrossRef
5. Proteomic analysis of malignant and benign endometrium according to obesity and insulin-resistance status using Reverse Phase Protein Array
   Olivia Raglan et al, 2020, Translational Research CrossRef
6. Evaluation of PIK3CA mutations as a biomarker in Chinese breast carcinomas from Western China
   Jingliang Cheng et al, 2017, Cancer Biomarkers CrossRef
7. Exogenous bacterial DnaK increases protein kinases activity in human cancer cell lines
   Francesca Benedetti et al, 2021, Journal of Translational Medicine CrossRef
8. Targeting PRAS40 for multiple diseases
   Zhao Zhong Chong, 2016, Drug Discovery Today CrossRef
9. mTOR in health and in sickness
   Dritan Liko et al, 2015, Journal of Molecular Medicine CrossRef